Showing results (101-110 of 536) with videos related to
Sort By:
Pageof 54
International Journal of Chronic Obstructive Pulmonary Disease|September 28, 2020
Symptom Improvement Following Treatment with the Inhaled Dual Phosphodiesterase 3 and 4 Inhibitor Ensifentrine in Patients with Moderate to Severe COPD - A Detailed AnalysisHenrik Watz, Kathleen Rickard, Tara Rheault, et al.International Journal of Chronic Obstructive Pulmonary Disease|September 14, 2012
Once-daily NVA237 improves exercise tolerance from the first dose in patients with COPD: the GLOW3 trialKai M Beeh, Dave Singh, Lilla Di Scala, et al.American Journal of Respiratory and Critical Care Medicine|May 16, 2023
Serum IL-8 as a Determinant of Response to Phosphodiesterase-4 Inhibition in Chronic Obstructive Pulmonary DiseaseMirco Govoni, Michele Bassi, Debora Santoro, et al.International Immunopharmacology|November 14, 2025
Anti-oxidative and anti-inflammatory effects of the phosphodiesterase 3/4 inhibitor ensifentrineSimon Lea, Jian Li, Kieran Littolff, et al.Cranio : the Journal of Craniomandibular Practice|May 19, 2007
Evaluation of the posterior airway space following Biobloc therapy: geometric morphometricsG Dave Singh, Ana Victoria Garcia-Motta, William M HangInternational Journal of Chronic Obstructive Pulmonary Disease|July 20, 2018
Feasibility and challenges of using multiple breath washout in COPDAlan S Bell, Philip J Lawrence, Dave Singh, et al.The European Respiratory Journal|October 13, 2012
Increased phosphorylated p38 mitogen-activated protein kinase in COPD lungsKate Gaffey, Sophie Reynolds, Jonathan Plumb, et al.Science Advances|September 25, 2019
Unfolding adsorption on metal nanoparticles: Connecting stability with catalysisJames Dean, Michael G Taylor, Giannis MpourmpakisClinical & Translational Immunology|October 3, 2022
Increased mast cell activation in eosinophilic chronic obstructive pulmonary diseaseAndrew Higham, Josiah Dungwa, Tuyet-Hang Pham, et al.Therapeutic Advances in Respiratory Disease|May 18, 2019
Aclidinium bromide in fixed-dose combination with formoterol fumarate in the management of COPD: an update on the evidence baseAnthony D D'Urzo, Dave Singh, James F Donohue, et al.Pageof 54